|
Pubblicato nel 25/09/2007 à 15:08
Da rimonabantorder
Rimonabant is predictable to strike the Canadian weight loss market in this year. The Canadian drug approval procedure in general proceeds at a much slower speed in comparison with the US FDA course of action. Although, there has been no indication that French drug maker, Sanofi-Aventis has yet filed for endorsement of Rimonabant (Acomplia) in Canada. What is Rimonabant? Rimonabant is an effectual appetite suppressant which constitutes the active constituent in Acomplia drug, which is developed by Sanofi-Aventis, a French drug-maker. It acts by overcrowding the CB-1 receptors, which are located in the brain as well as in some of the body’s tangential tissues for instance fat cells, which are associated with glucose and lipid metabolism. Weight loss is not the only benefit sourced by Rimonabant usage. Other benefits are also proven in the 2 years of clinical trials such as smoking cessation, improvement in cardio-metabolic risk factors, and also reduces chances of weight regain. Usual approved dosage for usage is 20mg Rimonabant, which is to be consumed with a glassful of water. Sought-after weight loss results can be achieved with Acomplia(Rimonabant) diet drug when combined with a low calorie diet plan and regular exercise regime. Few Rimonabant side effects as displayed in the 2 years of clinical trials can be accounted as irritability, muscle cramp, vomiting, stomach upset, anxiety, nausea. Rimonabant side effects are a reflection of bodily changes to this medication. These Rimonabant side effects are short-lived and dwindle away as soon as one fine-tunes to the Rimonabant weight loss prescription. Incase, you experience any of the above stated side effects for an extensive time span, talk to your doctor. Individuals under the age of 18 years, diabetics, heart patients, women planning pregnancy, expectant women, and breast-feeding mothers should circumvent use of Acomplia diet pill. Ensure that your general practitioner is well-acquainted concerning your medical record to shun any contraindication which may be sourced due to Acomplia medication usage.
Pubblicato nel 08/07/2007 à 23:05
Da rimonabantorder
Rimonabant ws. Phentermine Advantages of Rimonabant: non controlled drug very few side effects low priced, generic available
Disadvantages of Phentermine: Controlled (legal problems) Very nasty side effects (Shakes, Anxiety, Jitters ) Unreliable sources and high priced
Rimonabant ws Phnetermine These are just a few advantages and disadvantages of Rimonabant and Phentermine. To put it in one word Rimonabant Acomplia is way better than Phentermine. For more information you can talk to your doctor or to our specialists via online support or mail. We are here to answer your questions and give you the best advice for you! See for yourself ;)
Pubblicato nel 18/06/2007 à 12:04
Da rimonabantorder
Rimonabant ReviewRimonabant (SR141716) is an anorectic anti-obesity drug. It is a CB1 cannabinoid receptor antagonist. Its main avenue of effect is reduction in appetite. Rimonabant is the first selective CB1 receptor blocker to be approved for use anywhere in the world. In Europe, it is indicated for use in conjunction with diet and exercise for patients with a body mass index greater than 30 kg/m², or patients wih a BMI greater than 27 kg/m² with associated risk factors, such as type 2 diabetes or dyslipidaemia. In the UK, it has been available since the end of July 2006. Rimonabant ReviewOn 21 June 2006, the European Commission approved the sale of rimonabant in the then 25-member European Union. Sanofi announced that the first country in which Acomplia will be sold is the United Kingdom. Sales began in July 2006. Sanofi also announced that it projects that the drug will be sold shortly thereafter in Denmark, Ireland, Germany, Finland and Norway. It is expected in Belgium [3] and Sweden in 2007. Ordinary obesity will, according to official medical recommendations, not be enough to acquire the prescription in Sweden; there are additional requirements concerning abnormal blood lipid levels. [4] The EU's approval was not a blanket approval, nor did it approve Acomplia for non-obesity related problems such as smoking cessation, although off-label use of the drug is still possible. The approval is in combination with diet and exercise for the treatment of obese patients (BMI greater than or equal to 30), or overweight patients (BMI greater than 27) with associated risk factors, such as type 2 diabetes or dyslipidaemia. Rimonabant Review Hopping that i made things a little bit clearer now go ahead an place your order. Please feel free to comment on any of the articles here for any questions
Pubblicato nel 18/06/2007 à 12:01
Da rimonabantorder
Rimonabant No Prescription As i said in one of my previous hints, you can order Rimonabant without any prescription. I have been asked by mail if there is any catch. Well let me tell you that it is perfectly legal and there is no catch in ordering rimonabant without a prescription
Rmonabant No Prescription I'm still advising you to consult a doctor or our online support before you make your purchase of Rimonabant. Why do that? Well because you must be shure before you buy any pills.
Rimonabant No Prescription Hopping that i made things a little bit clearer now go ahead an place your order. Please feel free to comment on any of the articles here for any questions
Pubblicato nel 18/06/2007 à 11:53
Da rimonabantorder
Rimonabant Canada
Rimonabant, also available in Canada. The real deal for you! Lose weight with no real effort! Souds great dosen't it? Rimonabant Canada
Our Canadian online pharmacy offer online support for those of you who need more information about Rimonabant. Rimonabant Canada
Rimonabant is currently being sold in the United Kingdom by Sanofi-Aventis and in Denmark by Sanofi-Synthelabo under the trade name Acomplia. Slimona and Rimoslim are generic forms available in India. It is made also available all over the world Canada, US, Japan, you name it by ordering online. in one day max you'll get what you need!
|
|
<
|
Jui. 2009 |
|
| L |
M |
M |
J |
V |
S |
D |
| | | 1 | 2 | 3 | 4 | 5 | | 6 | 7 | 8 | 9 | 10 | 11 | 12 | | 13 | 14 | 15 | 16 | 17 | 18 | 19 | | 20 | 21 | 22 | 23 | 24 | 25 | 26 | | 27 | 28 | 29 | 30 | 31 | | |
Valutare questo blog :
90 collegati
9476 ospites
Nessun link da pubblicare
|